Bridgetech Holdings, Inc. Rated 'Outperform' Target $12.78 by Investrend Research Affiliate Beacon Equity Research.NEW YORK -- (Investrend Research Syndicate) Bridgetech Holdings, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). : BGTH) has been rated "Outperform" with a price target of $12.78 by Investrend Research affiliate Beacon Equity Research. The report is authored by Senior Research Analyst, Michael Pajak, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , CPA (Computer Press Association, Landing, NJ) An earlier membership organization founded in 1983 that promoted excellence in computer journalism. Its annual awards honored outstanding examples in print, broadcast and electronic media. The CPA disbanded in 2000. . The full report is available at http://www.beaconequityresearch.com and http://www.investrendresearch.com. In the report Mr. Pajak writes, "For valuation and comparison purposes, other potential competitors in this space include China Medical Technologies, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CMED CMED Coordinated Medical Emergency Direction CMED Central Massachusetts Emergency Dispatch ) and North American Scientific, Inc. (NASDAQ: NASI (1) (NetWare Asynchronous Service Interface) A protocol from Novell for connecting to modems in a communications server. It was derived from the NCSI protocol. NASI provides more advanced features than the common int 14 (interrupt 14) method. ). The Company believes that there is no major competitor established yet in China and only a few CRO's are focused on the Chinese market. Some of the CRO's presently operating in China are Kendle International, Inc. (NASDAQ: KNDL), Covance, Inc. (NYSE NYSE See: New York Stock Exchange : CVD CVD Cardiovascular disease, see there ) and Omnicare, Inc. (NYSE: OCR). The company's business strategy primarily focuses on facilitating the transfer of medical drugs, devices and diagnostics from the United States to targeted revenue markets in Asia, especially the Chinese healthcare market. Bridgetech expects that most of its sources of intellectual rights will be hospitals, hospital groups and university health systems. The firm's strategy leverages the considerable discovery and development investment already made in these products. For instance, investment into product development currently in the Company's pipeline exceed $500 million, while its financial commitment to obtain the Chinese rights stands at less than $1 million. Further, the Company claims that it has minimized the financial risks associated with early product development as the product has been thoroughly validated before it enters into an agreement." Beacon Equity Research, LLC is a fee-based, comprehensive investment research firm, focusing primarily on the underserved small-cap sector. All Beacon analysts are seasoned industry professionals and adhere to the CFA Institute's (CFAI CFAI Commission on Fire Accreditation International CFAI Central Florida Autism Institute ) stringent ethics and standards of practice guidelines. Beacon Research does not have any investment banking relationships with any of the companies covered. All analysts are compensated prior to performing their investment research and are not compensated in any way based on the future performance of the equities they follow. Both Beacon Equity Research and Investrend subscribe to the "Standards for Independent Research Providers" at http://www.firstresearchconsortium.com and the research is enrolled for investor-monitoring by the not-for-profit Shareholders Research Alliance, Inc. (http://www.shareholdersresearch.com). Beacon Research Partners has been compensated $12,000 dollars by Bridgetech Holdings, Inc. for six months of enrollment in its research program. Complete information is available at the company's InvestorPower page at http://www.investrend.com/company/list.asp?sPathParam=yes. Investors are advised to read disclosures carefully before trading in the equities of any enrolled company. Anyone interested in receiving alerts regarding Bridgetech Holdings, Inc. research should email members@beaconequityresearch.com and contact@investrend.com with "BGTH" in the subject line. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion